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Abstract
Background: The incidents of drug resistant microorganisms and the need of treatments for newly emerging
pathogens are of great concern to the global community. Our ability to treat infectious diseases is dependent on
the development of new pharmaceuticals, and one potential source being medicinal plants with traditional claims.
The leaves of Aloe trigonantha L.C. Leach, an endemic Ethiopian plant, are locally used for the treatment of
infectious and inflammatory diseases. This study explores the potential of the latex of this plant and compounds
isolated thereof for their in vitro antibacterial and antifungal properties.
Methods: Analytical RP-HPLC and silica gel preparative TLC were used for identification and isolation of active
constituents, respectively. Characterization of the compounds was based on UV, IR, HR-ESIMS, 1H and 13C NMR, and
2D-NMR spectral assignments. Antimicrobial activity studies were carried out against 21 pathogenic bacterial and 4
fungal strains using the disk diffusion method. Minimum inhibitory concentrations (MICs) were determined by the
broth dilution method.
Results: A C-glycosylated chromone identified as aloesin, and three C-glycosylated anthrones characterized as 8-O-
methy-7-hydroxyaloin A/B, aloin A/B and aloin-6’-O-acetate A/B were isolated. The latex and isolated compounds
exhibited in vitro antibacterial activity against the tested pathogens. In some cases the activity of the isolated
compounds (MIC = 10 μg/mL) was comparable with that of the standard drug ciprofloxacin, particularly against
some of the Gram-negative bacterial strains tested. However, their activity towards the fungal pathogens tested was
relatively weaker showing maximum activity against Candida albicans with MIC value of 400 μg/mL.
Conclusion: The present findings can be used for further research aimed at the development of new antibacterial
agents, and may also justify the ethnomedicinal claim of the plant for the treatment of infectious diseases.
Keywords: Aloe trigonantha, Antimicrobial activity, 8-O-methy-7-hydroxyaloin A/B, Aloesin, Aloin A/B, Aloin-6’-O-
acetate A/B, Disk diffusion
Background
Microbial diseases are among the major causes of mor-
bidity and mortality in the world, and particularly in
developing countries [1, 2]. Regardless of the extensive
works done towards the control of microorganisms, in-
cidents of drug resistant microorganisms, reduction in
new antimicrobials in pharmaceutical pipeline and the
need of treatments for newly emerging pathogens pose
an enormous threat to public health [3]. A report
compiled by WHO indicates that devoid of urgent and
coordinated action, the world is heading towards a
post-antibiotic era in which common infections and
minor injuries, which have been treatable for decades,
can once again kill [4]. These negative health trends
have driven a global initiative towards the search for
new sources of antimicrobial substances mainly from
medicinal plants. Medicinal plants represent rich
sources of antimicrobials with higher activity and re-
duced side effects. It is, therefore, suggested to carry
out an intense screening of these plants in order to
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validate their use in folk medicine and isolate the
active principle(s) [5–7].
The genus Aloe is represented by 600 species and be-
longs to the family of Asphodelaceae [8, 9]. Aloe plants
are native to sub-Saharan Africa, many islands of western
Indian Ocean, including Madagascar and Saudi Arabian
Peninsula. In Ethiopia and Eritrea, about 46 species of
Aloe have been described so far with a high proportion of
endemics adapted to harsh climates [10]. It has been
reported that the leaf latex of several Aloe species and
their constituents possess wide spectrum of biological
activities, such as antimicrobial [11, 12], antimalarial
[13], and antiglycation [14].
Aloe trigonantha L.C. Leach, locally called ‘Eret’, is
among the endemic Aloe species of Ethiopia, which has
been described in 1971 in an area between the cities of
Bahir Dar and Gonder in the northern part of the
country. Like many other Aloe species found in
Ethiopia with ethnomedicinal applications [15, 16], the
local people extensively use the leaves of A. trigonantha
for the treatment of infectious and inflammatory diseases
[17]. However, despite its use in traditional medicine and
possible therapeutic applications, no phytochemical or
biological studies carried out on the plant could be found
in the literature. The purpose of this study is, therefore, to
test the latex against a panel of microbes to characterize
its antimicrobial effect. The report further details the ex-
traction, isolation, identification and structural elucidation
of the antimicrobial compounds of the latex.
Methods
Plant material
The latex of A. trigonantha was collected in January
2011 from Kutkuatema, a small village 568 km north-
west of Addis Ababa, Ethiopia. The plant was authenti-
cated by Professor Sebsebe Demissew, the National
Herbarium, Department of Biology (DoB), Addis Ababa
University (AAU) where voucher specimen was depos-
ited with collection number MD 001.
Bacterial strains
In vitro antibacterial assays were carried out against the
following Gram-positive bacterial strains: Bacillus pumi-
lus 82, B. subtilis ATCC 6633 and Staphylococcus aureus
ML 267. The Gram-negative bacterial strains used were:
Escherichia coli 3:37C, E. coli 7360, E. coli 872, E. coli
CD/99/1, E. coli K 88, E. coli T 37, E. coli ROW 7/12, E.
coli 5933, Salmonella enterica TD 01, S. typhi Ty2,
Shigella boydii D13629, S. dysentery 8, S. flexneri Type 6,
S. soneii 1, Vibrio cholerae NCTC 5596, V. cholerae
NCTC 10732, V. cholerae NCTC 11501, and V. cholerae
NCTC 4693. All the bacterial strains were procured
from the Department of Technology, Jadavpur Univer-
sity; Central Drugs Laboratory, Kolkata and Institute of
Microbial Technology, Chandigarh, India. The purity of
the strains was checked according to the standard
microbiological, cultural and biochemical tests prior to
sensitivity tests against the test samples.
Fungal strains
Antifungal activity testing was carried out on the follow-
ing fungal pathogens: Aspargillus niger ATCC 6275,
Candida albicans ATCC 10231, Penicillium funiclosum
NCTC 287and P. notatum ATCC 11625. All the fungal
strains were procured from Central Drugs Laboratory,
Kolkata, India.
Instrumental analysis
UV spectra were recorded on a Shimadzu Spectrophotom-
eter MultiSpec-1501 (200-400 nm) at room temp. IR spec-
tra were carried out in KBr plates on a Perkin-Elmer BX
(400–4000 cm−1) instrument. HPLC was performed using
an UltiMate 3000 Standard HPLC Systems equipped with
a UV photodiode array detector (190–400 nm). ESI-MS
were recorded on an Ultimate 3000 LC-MS with negative
mode. The source voltage and temperature were fixed
at 3 kV and 250 °C. NMR spectra were recorded on a
Bruker Avance DMX400 FT-NMR spectrometer operating
at 400 MHz for 1H and 100 MHz for 13C at room
temperature. Signals were referred to an internal standard
TMS. Chemical shifts were reported in δ units and
coupling constants (J) in Hz.
Extraction of the latex
The leaf latex of A. trigonantha was collected by cutting
the leaves transversally near the base and arranging
them concentrically around a plate. The latex was then
left in open air for three days to allow evaporation of
water, which yielded a dark brown powder.
HPLC operating conditions
HPLC was performed using a Phenomenex IB-Sil C-18 re-
versed phase column (250 mm x 3.2 mm, 5 μm diameter
particles); flow rate 1 mL/min. The solvent system consists
of 30 % to 60 % linear gradient of methanol in water over
25 min, 3 min isocratic, 100 % in 2 min, 4 min isocratic.
UV absorption spectra were recorded at 254 nm.
Isolation of compounds
The latex was dissolved in methanol and applied dir-
ectly to preparative thin layer chromatography (PTLC)
plates over silica gel G6 F254 (Merck; 20 cm × 20 cm;
0.50 mm thickness). A solvent system of EtOAc/
MeOH/H2O (77:13:10) was used for isolation. PTLC
plates with 0.25 mm thickness were used to further
purify the compounds. Chromatographic zones were
visualized first in daylight and then under ultraviolet
light of wavelengths 254 and 366 nm. The bands were
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scraped off, washed with EtOAc/MeOH (1:1) and filtered
to yield four compounds (1–4).
Aloesin (1): A pale yellow amorphous solid; 6.8 % (w/w);
HPLC: tR = 11.70 min; TLC: Rf = 0.32 (EtOAc/MeOH/
H2O-77:13:10); UV λmax (MeOH): 215, 244, 253, 295 nm;
IR νcm-1: 3436, 2923, 1684, 1384. LRESI-MS (−ve mode)
m/z: 393[M-H]−, indicating a molecular formula of
C19H22O9.
1H NMR (DMSO) δ: 2.25 (3H, s, 11-CH3),
2.62 (1H, s, 5-CH3), 3.15-3.70 (5H, m, H-2’-H-6’), 3.21
(1H, s, H-9), 4.70 (1H, brs, H’-1), 6.12 (1H, s, H-3), 6.69
(1H, s, H-6). 13C NMR (DMSO): 23.06 (5-CH3), 30.26
(11-CH3), 47.97 (9-CH2), 61.80 (C-6’), 73.88 (C-1’), 70.83
(C-4’), 71.10 (C-2’), 79.02 (C-2’), 81.56 (C-5’), 110.88
(C-8), 112.48 (C-3), 114.27 (C-4a), 117.97 (C-6),
147.84 (C-1a), 160.65 (C-7), 163.66 (C-2), 179.47 (C-4),
140.48 (C-5), 203.82 (C-10).
8-O-Methyl-7-hydroxyaloin A/B (2): A brown
amorphous solid; 12.5 % (w/w); HPLC: tR =16.87 min;
TLC: Rf = 0.35 (EtOAc/MeOH/H2O-77:13:10); UVλmax
(MeOH): 199, 222, 294, 348 nm; IRνcm-1: 3411, 2853,
1636. HRESI-MS (+ve mode) m/z: 471.12640 [M+Na]+,
(calcd. for C22H24O10 471.12617 [M+Na]
+).
1H NMR
(DMSO) δ: 1.2-3.5 (H-5’, m, H-2’- H-6’), 3.2 (1H, brs,
H-1’), 3.81 (3H, s, 8-OCH3), 4.43 (1H, d, H-10), 4.48
(1H, brs, H-2), 6.75 (1H, brs, H-2), 6.78 (1H, brs, H-4),
7.05 (1H, d, H-6), 7.14 (1H, d, H-5), 8.41 (1H, s, 7-OH),
12.16 (1H, s, 1-OH). 13C NMR (DMSO) δ: 44.10 (C-10),
61.40 (8-OCH3), 62.10 (C-6’), 62.90 (3-OCH2), 70.90
(C-2’), 72.60 (C-4’), 78.40 (C-1’), 80.80 (C-3’), 84.20
(C-5’), 115.80 (C-4), 117.60 (C-5), 118.45 (C-8a),
120.80 (C-2), 125.30 (C-6), 127.90 (C-1a), 131.90 (C-4a),
140.86 (C-5a), 145.30 (C-7), 147.00 (C-8), 150.50 (C-3),
160.50 (C-1), 190.20 (C-9).
Aloin A/B (3): A pale yellow amorphous powder;
15.7 % (w/w); HPLC: tR = 22.19 min; TLC: Rf = 0.39
(EtOAc/MeOH/H2O-77:13:10); UV λmax (MeOH) :
208, 299, 357 nm; IR νcm‑1: 3447, 1631, 1618; LRESI-
MS (−ve mode) m/z: 417 [M‑H]−, indicating a
relative molecular weight (Mr) of 418 (C21H22O9);
1H
and13C NMR chemical shift of compound 3 were in a
good agreement with those reported for the same
compound [11, 12].
Aloin-6’-O-acetate A/B (4): A pale yellow amorphous
solid; 18.4 % (w/w); HPLC: tR = 23.87 min; TLC: Rf =
0.63 (EtOAc/MeOH/H2O-77:13:10); UV: λmax (MeOH):
200, 269, 293 and 359 nm; IR νcm-1: 3400, 2922, 1719,
1603, 1451 and 1383. HRESI-MS (+ve mode) m/z:
483.12624 [M +Na] +, (calcd. for C23H24O10 483.12617
[M+ Na] +). 1H NMR (DMSO) δ: 1.2-3.7 (5H, m, H-2’-
H-6’), 2.1 (3H, s, COCH3), 3.21 (1H, dd, H-1’), 4.59
(2H, d, 11-CH2), 4.83 (1H, brs, H-10), 6.76 (1H, s, H-2),
6.97 (1H, brs, H-7), 7.23 (1H, brs, H-4), 7.38 (1H, d, H-5),
7.43 (1H, dd, H-6), 11.79 (1H, s, 1-OH), 11.80 (1H, s, 8-
OH).13C NMR (DMSO) δ: 21.20 (C-7’), 44.50 (C-10),
61.80 (C-11), 65.03 (C-6’), 70.68 (C-2’), 70.70 (C-4’), 78.60
(C-3’), 81.30 (C-5’), 85.4 (C-1’), 114.20 (C-2), 115.00
(C-1a), 115.90 (C-7), 117.80 (C-8a), 119.20 (C-4),
120.70 (C-5), 136.80 (C-6), 142.30 (C-4a), 144.7 (C-5a),
150.50 (C-3), 161.20 (C-1), 161.30 (C-8), 170.80 (C-8’),
193.75 (C-9).
In vitro antibacterial activity test
In vitro antibacterial assay was screened by the disc dif-
fusion method as described by Mitchell and Carter [18],
by determining zones of inhibition produced by the test
samples and comparing them with those of ciprofloxa-
cin. A stock solution of the latex and various isolated
compounds was prepared in 1 % DMSO (1 mg/ml) for
the antibacterial activity tests and 10 mg/ml for the anti-
fungal activity tests. Concentrations ranging from 5 to
800 μg/mL for antibacterial activity tests, and 50 to
2000 μg/mL for antifungal activity tests were employed
by diluting the stock solution in appropriate volumes of
water. Serial nutrient agar plates were then prepared by
pouring of molten media into sterile Petri dishes and
incubated at 37 °C for 24 h to check for any sort of con-
tamination. The inoculums were then swabbed uniformly
and allowed to dry for 5 min. Then, the filter paper discs
(Whatman no. 1) of 6 mm were impregnated with the test
samples and placed on the surface of the medium. The
Petri dishes were then incubated at 37 °C for 24 h and the
diameter of zone of inhibition was measured in mm. Simi-
lar procedure was adopted for ciprofloxacin and the corre-
sponding zone of inhibition was compared accordingly.
1 % DMSO was used as a negative control.
In vitro antifungal activity test
The antifungal potential of the test samples (2000 μg/mL)
was screened by disc diffusion method (as described for
the determination of antibacterial activity) against the fun-
gal pathogens on Saborauds dextrose media. The Petri
dishes were incubated at room temperature for 3 days and
the diameter of zone of inhibition was measured in mm.
Griseofulvin was used as a reference standard.
Determination of minimum inhibitory concentrations (MICs)
The MICs of the latex and isolated compounds were de-
termined by the broth dilution method, as described by
Hecht et al. [19]. Nutrient agar and Saborauds dextrose
agar were used for bacterial and fungal growth, respect-
ively. Concentrations ranging from 5 to 800 μg/mL for
antibacterial activity tests, and 50 to 2000 μg/mL for anti-
fungal activity tests were employed by dissolving the test
samples in DMSO. A sterility control was also carried out
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(growth control contained nutrient broth plus DMSO,
without antimicrobial substances). Each test and growth
control well was incubated for 24 h at 37 °C for bacteria
and 3 days at 25 °C for fungi.
Results and discussion
Structure elucidation
Reversed phase-HPLC analysis of the leaf latex of A.
trigonantha revealed the presence of four major com-
pounds (Fig. 1), identified as aloesin (1), 8-O-methy-7-
hydroxyaloin A/B (2) aloin A/B (3) and aloin-6’-O-acetate
A/B (4) by spectroscopic techniques including ESIMS,
1H, 13C NMR and DEPT-135 spectral data.
Compound 1, isolated as a pale yellow amorphous
solid, showed [M-H]− at m/z = 393 in the negative-mode
LRESI-mass spectrum, indicating a relative molecular
weight of 394. A molecular formula of C19H22O9 was de-
duced based on LRESI-MS, 1H and 13C and DEPT 135
spectral data. The presence of a chromone skeleton was
deduced from the UV spectrum (λmax: 215, 244, 253 and
295 nm) [20], 1H and 13C NMR spectral data. Hence,
compound 1 was unequivocally identified as 2-acetonyl-
8-β-D-glucopyranosyl-7-hydroxy-5-methylchromone,
commonly known as aloesin (Fig. 2) by comparing its 1H
and 13C NMR data with those reported for the same
compound in the literature [21].
Compound 2 was isolated as a brown amorphous
solid. The positive-mode HRESI-mass spectrum of com-
pound 2 gave a pseudomolecular ion at m/z 471.12640
[M +Na]+, corresponding to a molecular formula of
C22H24O10 (calcd. 471.12617). It was identified as an
anthrone derivative from the UV spectrum (λmax: 199,
222, 294 and 348 nm), 1H and 13C NMR spectral data
[20]. The1H and 13C NMR spectral data of compound 2
revealed that the signals mostly appear either in pairs or
overlapping on one another further suggesting that the
compound is a mixture of two closely related compounds.
Hence, compound 2 was unambiguously characterized as
the known 8-O-methyl-7-hydroxyaloin A/B (10-C-β-D-
glucopyranosyl-1,7-dihydroxy-8-O-methyl-9-anthracen-
one) (Fig. 2) by comparing its 1H and 13C NMR spectra
data (listed in the Method section) with those reported
for the related compound, homonataloin [22].
Compound 3 was obtained as a yellow amorphous
solid with a pseudomolecular ion at m/z: 417 [M-H]−
in negative-mode ESI-mass spectrum. A molecular for-
mula of C21H22O9 was determined based on its ESI-
MS, 1H and 13C NMR spectral data. Thus, compound
3 was unequivocally characterized as aloin A/B, which
was previously isolated from a number of Aloe species,
by comparing its 1H and 13C NMR spectral data with
those data reported in the literature for the same com-
pound [11, 12].
Compound 4 was obtained as a yellow amorphous solid
with the positive-mode HR-ESI mass spectrum showing a
pseudomolocular ion at m/z = 483.12624 [M+Na] +, indi-
cating a molecular formula of C23H24O10 (calcd.
483.12617). The presence of an anthrone moiety in com-
pound 4 was confirmed from its UV (λmax: 200, 269, 293
and 359 nm), 1H and 13C NMR spectral data. A close ana-
lysis of the 1H and 13C NMR spectra revealed that the sig-
nals occurred in pairs, indicating that it was a mixture of
two closely related compounds. Consequently, from its
spectral data summarized in the Method section, and by
comparing this data with those previously reported for the
same compound [23], compound 4 was identified as 10-
C-β-D-glucopyranosyl-1,8-dihydroxy-3-hydroxymethyl-6’-
O-acetate-9(10H)-anthracenone, otherwise known as aloin-
6’-O-acetate A/B (Fig. 2). Literature survey indicates that
aloin-6’-O-acetate A/B (4) is a rare natural product being
previously isolated only once from the leaf latex of Aloe
trichosantha [23].
Antibacterial activity
In the present study, the leaf latex of A. trigonantha was
evaluated against 21 bacteria strains using the disc diffu-
sion method. Our experiments showed that the latex
possesses activity against most of the bacterial strains
tested (Table 1). Whilst the Gram-negative bacteria in-
cluding all the strains of E. coli and Salmonella spp were
particularly susceptible to the latex, the Gram-positive
rod bacteria Bacillus pumilus and B. subtilis appeared to
be resistant. In vitro antibacterial activity of the leaf latex
of Aloe harlana had previously been examined in our la-
boratory showing the strongest activity against several
Gram-negative bacterial strains [11]. Similarly, Mariap-
pan and Shanthi [24] reported the inhibition of Salmon-
ella spp, Shigella sonie and Staphylococcus spp by the
leaf latex of Aloe vera with MIC values of 12.3, 4.2 and
12.4 μg/mL, respectively.
Fig. 1 HPLC chromatogram of the leaf latex of Aloe trigonantha.
Column: RP-18 (250 mm x 3.2 mm, 5 μm diameter particles); flow
rate 1 mL/min; UV detection: 254 nm; Solvent system: 30 % to 60 %
linear gradient of methanol in water over 25 min, 3 min isocratic,
100 % in 2 min, 4 min isocratic
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In view of the promising antimicrobial growth inhibi-
tory effect of the latex, it was further subjected to com-
pound isolation with the aim of finding more potent
antibacterial agent(s). As shown in Table 1, the isolated
compounds inhibited growth of most of the bacterial
strains tested showing lower MIC values against most
strains of E. coli and V. cholera than that of the latex. In
particular, aloin A/B (3) showed potent action against all
strains with the exception of Bacillus spp., and Salmon-
ella enterica, which showed limited susceptibility. Aloin
isolated from the latex of A. trigonantha also showed
powerful inhibitory activity and its action was similar to
aloin isolated from the latex of A. sinana reported in our
previous work [12]. In general, the antibacterial profile
of the latex was similar to those of the isolated compounds,
being able to inhibit mainly the growth of Gram-negative
bacteria. It appears that there was synergy among the iso-
lated compounds as the MIC values of the latex was
smaller than those of compounds 1 and 2 against Shigella
soneii and Salmonella enterica, respectively. In spite of the
fact that components of the latex belong to two different
classes of secondary metabolites, their antibacterial activity
was comparable with each other. Aloesin (1) is a chromone
while the others are anthrone glycosides. Previous studies
have demonstrated that natural chromones isolated from
diverse plant species such as Cassia petersiana (Fabaceae)
[25], Ferula communis (Apiaceae) [26] and Aloe barbaden-
sis (Asphodelaceae) [27] as well as synthetic phosphonic
derivatives of chromones [28] have activity towards
Gram-negative and Gram-positive bacteria. Similarly,
anthraquinones which are structurally related to anthrones
have been shown to inhibit growth of several pathogenic
microorganisms [29, 30].
The mechanism of action by which chromones and
anthrones exert their antibacterial action is not well
studied. Whilst Hamman [31] proposed that the antibac-
terial activity of anthraquinones isolated from the latex
of A. vera is through mediation of solute transport in-
hibition in membranes, Ubbink-Kok et al. [32] reported
that emodin and emodin anthrone are active against E.
coli by inhibiting respiration-driven transport within
membranes. Similar mechanisms of action could be pro-
posed for 8-O-methyl-7-hydroxyaloin A/B (2), aloin A/B
(3) and aloin-6’-O-acetate A/B (4) owing to their struc-
tural similarity to anthraquinones. However, further
studies are needed to establish the actual mechanism(s)
of action for these classes of compounds.
Among the bacterial strains tested, only the Gram-
positive bacilli bacteria were found to be resistant to the
latex and its components. Similarly, the single Gram-
positive strain of S. aureus tested in the present study
was shown to have a limited susceptibility to both the
latex and its components. It is interesting to note that
nearly all the Gram-negative pathogens tested were sus-
ceptible to both the latex and isolated compounds al-
though they have phospholipid membrane carrying the
structural lipopolysaccharide component that makes
their cell wall impermeable to antimicrobial substances.
This situation can be explained in terms of the chemical
nature of the test samples, which could have an effect
on the permeability and integrity of the bacterial cell
wall. According to Alves et al. [33], the anthraquinones
emodin and barbaloin affect the phospholipid mem-
branes of bacterial cell wall resulting in remarkable
changes in membrane physical properties including
changes of the lipid/water interface in negatively charged
Fig. 2 Structures of (a) aloesin (1); (b) 8-O-methyl-7-hydroxyaloin A/B (2), aloin A/B (3) and aloin-6’-O-acetate A/B (4)
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phospholipids and perturbations of the core of the
phospholipid bilayer.
Antifungal activity
The fungi tested in the present study were shown to
have limited susceptibility to both the latex and its com-
ponents although zones of inhibition displayed by the
latex were somewhat smaller than those obtained for the
isolated compounds. Among the fungal strains tested, C.
albicans was found to be more susceptible (MIC = 400–
800 μg/mL) to the test compounds than the other fungal
pathogens, which exhibited different levels of sensitivity.
Previous studies in our laboratory have found the
anthrones aloin and 7-O-methylaloeresin isolated from
the leaf latex of A. harlana to be capable of inhibiting
the growth of C. albicans, Penicillium funiculosum and
P. notatum to a similar extent observed in the present
study [11]. Moreover, aloin from A. ferox, emodin and
barbaloin from Rheum australe were shown to inhibit
the growth of C. albicans [34] and a range of pathogenic
fungal strains [35], respectively.
Conclusions
The findings of the present study have established the
susceptibilities of a broad range of bacteria particularly
Gram-negative pathogens to the latex of A. trichosantha
and its components. The Gram-positive strains tested
were either not inhibited by or showed limited susceptibil-
ity to any of the tested substances. The inhibitory effects
of the isolated compounds against various pathogenic mi-
croorganisms had clearly demonstrated the usefulness of
A. trichosantha in the treatment of various diseases caused
Table 1 Zones of inhibition and minimum inhibitory concentrations (MICs) of the latex and compounds isolated from Aloe
trigonantha
Microorganism Zones of inhibition in mm (200 μg/mL) MIC (μg/mL)i
Latexii 1ii 2ii 3 ii 4ii Cipro Latex 1 2 3 4
Bacillus pumilus 82 6.0 ± 0.0 6.0 ± 0.0a 6.0 ± 0.0a 10.0 ± 0.5b 6.0 ± 0.0a 19.0 ± 1.3 - - - 200 -
B. subtilis ATCC 6633 6.0 ± 0.0 6.0 ± 0.0a 6.0 ± 0.0a 10.0 ± 0.6b 6.0 ± 0.0a 18.0 ± 0.7 - - - 200 -
Escherichia coli 3:37C 15.0 ± 0.9 15.0 ± 1.2a 15.0 ± 0.9a 14.5 ± 0.5a 15.0 ± 0.7a 16.5 ± 0.8 50 25 25 10 25
E. coli 872 15.0 ± 0.7 14.5 ± 0.9a 14.5 ± 0.6a 14.5 ± 0.4a 14.5 ± 1.2a 16.0 ± 0.9 50 25 25 10 25
E. coli CD/99/1 15.0 ± 0.8 15.0 ± 0.7a 15.0 ± 0.8a 15.5 ± 0.9a 15.0 ± 0.9a 17.0 ± 1.4 50 25 25 10 25
E. coli K88 16.5 ± 1.1 15.5 ± 0.5b 15.5 ± 1.2b 15.0 ± 1.0b 15.5 ± 0.9b 17.0 ± 0.5 50 50 25 10 25
E. coli LT37 15.5 ± 0.6 14.5 ± 0.4b 14.5 ± 1.1b 14.5 ± 1.0b 14.5 ± 0.5b 16.0 ± 0.8 50 25 25 10 25
E. coli NCTC 5933 15.5 ± 1.2 15.0 ± 0.9a 14.5 ± 0.9b 14.5 ± 0.5b 15.0 ± 0.8a 16.0 ± 0.6 50 50 50 10 25
E. coli NCTC 7360 16.5 ± 1.0 15.5 ± 1.1b 14.5 ± 0.6b 14.5 ± 0.7b 15.5 ± 0.7b 17.0 ± 1.3 50 50 50 10 25
E. coli ROW 7/12 15.5 ± 0.7 15.0 ± 0.9a 15.0 ± 0.5a 14.5 ± 0.2a 15.0 ± 0.6a 16.5 ± 0.4 50 25 25 10 25
Salmonella enterica TD 01 16.5 ± 0.9 15.0 ± 0.6b 13.5 ± 0.8b 12.5 ± 0.5b 16.0 ± 1.2a 19.0 ± 0.9 50 50 100 50 25
S. typhi Ty2 15.0 ± 1.2 15.0 ± 0.8a 14.0 ± 0.7b 14.0 ± 0.6b 15.0 ± 0.9a 16.0 ± 0.5 50 25 50 10 25
Shigella boydii D 13629 15.0 ± 0.5 15.5 ± 0.8a 14.5 ± 0.9a 16.5 ± 0.4a 15.5 ± 0.6a 20.0 ± 0.7 50 50 50 10 50
S. dysentery 8 14.5 ± 0.8 14.0 ± 0.7a 13.5 ± 0.9b 15.5 ± 0.6b 13.5 ± 0.4b 20.0 ± 0.8 50 25 50 10 50
S. flexneri Type 6 15.0 ± 0.7 15.5 ± 0.5a 15.5 ± 0.6a 15.5 ± 0.5a 15.5 ± 0.7a 20.5 ± 0.7 50 50 50 10 50
S. soneii 1 15.0 ± 0.5 15.5 ± 0.9a 15.5 ± 0.8a 15.5 ± 0.5a 15.5 ± 0.6a 19.5 ± 1.2 50 100 50 10 50
Staphylococcus aureus ML 267 14.5 ± 0.9 14.5 ± 1.3a 14.5 ± 0.5a 14.5 ± 0.6a 13.5 ± 0.9b 18.0 ± 1.4 100 50 100 25 100
Vibrio cholerae NCTC 10732 14.0 ± 0.4 15.5 ± 0.8b 15.0 ± 1.1b 14.5 ± 1.0b 15.5 ± 0.9b 19.0 ± 0.9 50 25 25 10 25
V. cholerae NCTC 11501 14.5 ± 0.6 15.5 ± 0.4b 14.0 ± 0.7a 15.0 ± 0.3a 15.5 ± 0.7b 18.5 ± 0.8 50 25 25 10 25
V. cholerae NCTC 4693 13.5 ± 0.8 14.5 ± 0.9b 15.0 ± 0.8b 15.0 ± 0.3b 14.5 ± 0.9b 17.5 ± 0.5 50 25 25 10 25
V. cholerae NCTC 5596 14.0 ± 0.3 15.0 ± 0.7b 15.0 ± 0.7b 15.0 ± 0.5b 15.0 ± 0.5b 18.5 ± 0.8 50 25 25 10 25
Fungal strains Latexii 1ii 2ii 3ii 4ii Gris. Latex 1 2 3 4
Aspergillus niger ATCC 6275 9.0 ± 0.7 11.0 ± 1.3b 12.0 ± 0.9b 12.5 ± 0.6b 12.5 ± 0.9b 15.0 ± 0.9 1500 1000 1000 800 1000
Candida albicans ATCC 10231 10.0 ± 0.9 10.0 ± 0.8a 14.0 ± 1.2b 13.5 ± 1.0b 14.5 ± 0.8b 16.0 ± 1.3 800 400 400 800 400
Penicillium funiculosum NCTC 287 8.0 ± 0.6 9.5 ± 0.5a 12.5 ± 0.7b 12.0 ± 0.4b 13.5 ± 0.5b 13.5 ± 1.1 1000 800 800 800 400
P. notatum ATCC 11625 8.0 ± 0.8 10.0 ± 0.7b 12.5 ± 0.6b 12.0 ± 0.5b 12.5 ± 0.4b 13.5 ± 0.9 1000 800 800 800 400
iMIC expressed as an average from three independent experiments, each performed in triplicate; iiZones of inhibitions were expressed as means ± SEM including
the 6 mm diameter of the disc; a: p > 0.05 when compared to the latex on the same row; b: p < 0.05 when compared to the latex on the same row; 1: Aloesin,
2: 8-O-Methyl-7-hydroxyaloin A/B, 3: Aloin A/B; 4: Aloin-6’-O-acetate A/B; Cipro: Ciprofloxacin; Gris: Griseofulvin
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by these pathogenic strains and explains, in part or in
whole, the use of the plant in traditional medicine.
Furthermore, the identification of such natural anti-
microbial compounds may lead to the development of
novel antimicrobials through structure/activity studies.
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